Customer Service: 866-788-9007

Transforming the Management

of Dermatologic Cancers

Enabling More Accurate Treatment Plan Decisions With Our Line of Gene Expression Profile (GEP) Tests

CUTANEOUS MELANOMA

Dx-Melanoma-2r
PROGNOSTIC

Predicting Individual Risk of Recurrence or Metastasis in Stage I, II and III Melanoma

DiffDx-MelanomaStack-Color.svg
DIAGNOSTIC

A Highly Accurate and Objective Test Characterizing Difficult-to-Diagnose Melanocytic Lesions

SQUAMOUS CELL
CARCINOMA

Dx-Melanoma-1r1
PROGNOSTIC

Better Identifies Risk of Metastasis in Patients With One or More Risk Factors

UVEAL
MELANOMA

Dx-Melanoma-1r11
PROGNOSTIC

The Standard of Care for Uveal Melanoma Staging

WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

Scroll to Top